What We're Reading: Page 395
Industry reads hand-picked by our editors
Feb 26, 2015
-
FierceBiotech
Pfizer planning more layoffs in R&D
-
Merck, MPP team up to provide low-cost HIV pediatric meds in poor countries
-
-
-
French government slams Sanofi over new CEO's pay
-
-
Public Citizen requests FDA ban on certain antifungal meds
-
-
Shire keeps acquisition train rolling with $70M Meritage Pharma deal
-
Platinum parachute? Allergan CEO Pyott could get $100M exit fee
Feb 25, 2015
-
BMS strengthens oncology pipeline with two big deals worth $1.6B
-
-
Lilly's long-acting insulin not ready for prime time
-
Toronto Star retracts piece suggesting injuries linked to Merck's Gardasil
-
-
-
Duchenne, orphan drug maker PTC Therapeutics fielding takeover bids
-
-
Novartis' Farydak wins FDA approval for multiple myeloma
-
Is there still a place for the mighty pharmaceutical sales force?
Feb 24, 2015
-
FDA to review Pfizer's rare lung disease drug for women
-
UPDATE: Valeant to buy Salix for $10.1B, cleared for $495M Dendreon buyout
-
Compounding pharmacies chafe at FDA's disciplinary actions
-
-
Corgenix's 15-minute Ebola test approved by WHO
-
-
-
Holoclar makes history: Europe approves West's first stem-cell therapy
-
Cellectis files $115M IPO to fund unique CAR-T program
-
Feb 23, 2015
Feb 20, 2015
-
-
Biotech battle: Regeneron's Eylea bests Genenetch's Lucentis in head-to-head
-
Why FDA's label expansion for Celgene's Revlimid could foretell a global sales surge
-
-
-
Why so little uptake of preventive Truvada in the at-risk gay community?
-
Gilead's Harvoni supplants Sovaldi as top-selling launch drug
-
AstraZeneca's plan to unite R&D hubs takes flight
-
-
Feb 19, 2015
-
CVS fires controversial warning shot in opening salvo of PCSK9 price wars
-
The more, the merrier? Endo also pursuing Salix Pharma bid
-
-
-
Inotek slashes share price ahead of IPO
-
UPDATE: Bayer HealthCare chief Brandicourt named Sanofi's next CEO
-
GSK replaces US pharma ops head Connelly amid struggles
-
AstraZeneca's plan to unite R&D hubs takes flight
-
Shanghai official to serve 19 years over GSK bribery case
-
Feb 18, 2015
-
UPDATE: Bayer HealthCare chief Brandicourt named Sanofi's next CEO
-
GSK replaces US pharma ops head Connelly amid struggles
-
-
Can AZ finally solidify a deal for its anti-infectives unit?
-
Profits fall for India's largest drug maker
-
NAFTA patent spat rages on between Canada and Lilly
-
-
Eisai, Pfizer, and Novartis meds get FDA love over the long weekend
-
-
Previous
